Accelerate
medical writing with Generative AI

Yseop Copilot is reimagining the future of work for the largest pharmaceutical companies in the world

NEWS & PR, 24 JAN

THE PROMISE & CHALLENGE OF
DEPLOYING AI IN CLINICAL TRIALS

Pharmaceutical clinical trials present both a compelling and challenging use case for Artificial Intelligence. Yseop was recently featured in Forbes, showcasing how we accelerate the time to market in drug development. 
 
Screen Shot 2023-10-05 at 12.29.49 PM
Yseop Youtube Play Button

Scale medical and regulatory writing requirements with automation

Save time and money

Accelerate medical review time by 200% and increase efficiency of complex processes at scale.

Empower your people

Liberate teams from tedious, repetitive tasks and get back thousands of hours of writing and review time. 

Drive digital transformation

Modernize workflows and transform how your business operates to succeed in the new AI-powered world.

The leader in Generative AI for pharmaceutical companies, Yseop Copilot changes the way content automation solutions are delivered with a human-centric, AI platform.

Life Sciences

Offering fully configurable Automation Packs to accelerate core medical report writing needs

Automation for Life Sciences

Yseop helps bring drugs to market faster by automating the data analysis and report generation required by regulators.

Preclinical

Deliver highly accurate narratives by automating parts of the preclinical document review cycle.

Clinical

Our solution helps medical writers do more in less time by automating key clinical components of the CTD in module 2 and 5.

Quality
(Coming Soon)

Discover how automation saves lives, money, and quickens the march to market.

The future of work is augmented.

See how Yseop’s powerful medical writing AI can drastically cut time to market with full workflow automation.

quote icon.
quote icon.

News & Press Releases

At the forefront of innovations and developments in AI and NLG.

Reinforcing Yseop’s unique footprint in the GenAI space for BioPharma, a new investment enables Yseop to expand the scope of its Generative AI offerings and accelerate its leadership position in life sciences.
Reinforcing Yseop’s unique footprint in the GenAI space for BioPharma, a new investment enables Yseop to expand the scope of its Generative AI offerings and accelerate its leadership position in life sciences.
Yseop is thrilled to announce that we have been nominated for The World Technology Leader Award. We are in the company of prestigious nominees including OpenAI, BMW, and BASF.

Awards & Recognition

Global Generative AI Award

Winner in the Healthcare and Life Sciences category 

The World Technology Leader Award

2023 nominee at The World Technology Leader Awards, recognized along with OpenAI, BMW, and more. 

Citeline Awards, Best Use of Artificial Intelligence in Clinical Trials

Winner at the 2023 Citeline Awards for Best Use of AI in Clinical Trials.
Gartner Logo.

Recognized by Gartner as a Representative Vendor in its first Natural Language Generation Market Guide.

Gartner, Market Guide for Natural Language Generation Platforms

Efma Logo.

Efma-Capgemini Financial NewTech 2020 Watchlist

finance innovation logo.

Label Finance Innovation

IT Night silver prize: Category “Digital Innovation and AI”

ventana research award winner.

Top IT Innovation 2016 

banque innovation 2015.

Grand Prix « Banque and Innovation 2015

Speak to an AI Expert

Let’s start automating your data to narratives today!

Sign up for our newsletter to stay up to date with the latest Generative AI news from Yseop
Scroll to Top